Cargando…

Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Annually, about 200,000 patients died of HCC in China. Liver transplantation (LT) holds great theoretical appeal in treating HCC. However, the high recurrence rate after transplantation is the most important...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuliang, Shen, Zhongyang, Zhu, Zhijun, Han, Ruifa, Huai, Mingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206678/
https://www.ncbi.nlm.nih.gov/pubmed/22087143
_version_ 1782215472122429440
author Wang, Yuliang
Shen, Zhongyang
Zhu, Zhijun
Han, Ruifa
Huai, Mingsheng
author_facet Wang, Yuliang
Shen, Zhongyang
Zhu, Zhijun
Han, Ruifa
Huai, Mingsheng
author_sort Wang, Yuliang
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Annually, about 200,000 patients died of HCC in China. Liver transplantation (LT) holds great theoretical appeal in treating HCC. However, the high recurrence rate after transplantation is the most important limiting factor for long-term survival. OBJECTIVES: To assess the value of alpha-fetoprotein (AFP) messenger RNA (mRNA), Glypican-3 (GPC3) mRNA-expressing cells in the peripheral blood (PB) for prediction of HCC recurrence following orthotopic liver transplantation (OLT). PATIENTS AND METHODS: 29 patients with HCC who underwent OLT with a minimum clinical follow-up of 12 months were included in this retrospective study. We detected AFP mRNA, GPC3 mRNA-expressing cells in the PB by TaqMan real-time reverse transcriptase-polymerase chain reaction (RT-PCR), pre-, intra- and post-operatively. The early recurrence of patients was evaluated. RESULTS: 8 (28%), 15 (52%), and 9 (31%) patients had AFP mRNA detected pre-, intra-, and post-operatively, respectively. With 12 months of follow-up, HCC recurred in 7 (24%) patients. Univariate analysis revealed that positive pre- and post-operative AFP mRNA, TNM stage as well as vascular invasion were significant predictors for the HCC recurrence. Multivariate analysis revealed that being positive for AFP mRNA pre-operatively remained a significant risk factor for HCC recurrence after OLT. GPC3 mRNA was expressed in all PB samples. There was no significant difference in the expression levels of GPC3 mRNA between the HCC and control groups. There were no significant differences in GPC3 mRNA expression values between those patients with and without tumor recurrence. CONCLUSIONS: The pre-operative detection of circulating AFP mRNA-expressing cells could be a useful predictor for HCC recurrence following OLT. GPC3 mRNA-expressing cells in PB seem to have no diagnostic value.
format Online
Article
Text
id pubmed-3206678
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-32066782011-11-15 Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC Wang, Yuliang Shen, Zhongyang Zhu, Zhijun Han, Ruifa Huai, Mingsheng Hepat Mon Original Article BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Annually, about 200,000 patients died of HCC in China. Liver transplantation (LT) holds great theoretical appeal in treating HCC. However, the high recurrence rate after transplantation is the most important limiting factor for long-term survival. OBJECTIVES: To assess the value of alpha-fetoprotein (AFP) messenger RNA (mRNA), Glypican-3 (GPC3) mRNA-expressing cells in the peripheral blood (PB) for prediction of HCC recurrence following orthotopic liver transplantation (OLT). PATIENTS AND METHODS: 29 patients with HCC who underwent OLT with a minimum clinical follow-up of 12 months were included in this retrospective study. We detected AFP mRNA, GPC3 mRNA-expressing cells in the PB by TaqMan real-time reverse transcriptase-polymerase chain reaction (RT-PCR), pre-, intra- and post-operatively. The early recurrence of patients was evaluated. RESULTS: 8 (28%), 15 (52%), and 9 (31%) patients had AFP mRNA detected pre-, intra-, and post-operatively, respectively. With 12 months of follow-up, HCC recurred in 7 (24%) patients. Univariate analysis revealed that positive pre- and post-operative AFP mRNA, TNM stage as well as vascular invasion were significant predictors for the HCC recurrence. Multivariate analysis revealed that being positive for AFP mRNA pre-operatively remained a significant risk factor for HCC recurrence after OLT. GPC3 mRNA was expressed in all PB samples. There was no significant difference in the expression levels of GPC3 mRNA between the HCC and control groups. There were no significant differences in GPC3 mRNA expression values between those patients with and without tumor recurrence. CONCLUSIONS: The pre-operative detection of circulating AFP mRNA-expressing cells could be a useful predictor for HCC recurrence following OLT. GPC3 mRNA-expressing cells in PB seem to have no diagnostic value. Kowsar 2011-03-01 2011-03-01 /pmc/articles/PMC3206678/ /pubmed/22087143 Text en Copyright © 2011, Kowsar M.P. Co. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Wang, Yuliang
Shen, Zhongyang
Zhu, Zhijun
Han, Ruifa
Huai, Mingsheng
Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
title Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
title_full Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
title_fullStr Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
title_full_unstemmed Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
title_short Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
title_sort clinical values of afp, gpc3 mrna in peripheral blood for prediction of hepatocellular carcinoma recurrence following olt: afp, gpc3 mrna for prediction of hcc
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206678/
https://www.ncbi.nlm.nih.gov/pubmed/22087143
work_keys_str_mv AT wangyuliang clinicalvaluesofafpgpc3mrnainperipheralbloodforpredictionofhepatocellularcarcinomarecurrencefollowingoltafpgpc3mrnaforpredictionofhcc
AT shenzhongyang clinicalvaluesofafpgpc3mrnainperipheralbloodforpredictionofhepatocellularcarcinomarecurrencefollowingoltafpgpc3mrnaforpredictionofhcc
AT zhuzhijun clinicalvaluesofafpgpc3mrnainperipheralbloodforpredictionofhepatocellularcarcinomarecurrencefollowingoltafpgpc3mrnaforpredictionofhcc
AT hanruifa clinicalvaluesofafpgpc3mrnainperipheralbloodforpredictionofhepatocellularcarcinomarecurrencefollowingoltafpgpc3mrnaforpredictionofhcc
AT huaimingsheng clinicalvaluesofafpgpc3mrnainperipheralbloodforpredictionofhepatocellularcarcinomarecurrencefollowingoltafpgpc3mrnaforpredictionofhcc